AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Melse-Boonstra, A.
Right arrow Articles by Verhoef, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melse-Boonstra, A.
Right arrow Articles by Verhoef, P.
Agricola
Right arrow Articles by Melse-Boonstra, A.
Right arrow Articles by Verhoef, P.
American Journal of Clinical Nutrition, Vol. 79, No. 3, 424-429, March 2004
© 2004 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATION

Bioavailability of heptaglutamyl relative to monoglutamyl folic acid in healthy adults1,2,3

Alida Melse-Boonstra, Clive E West, Martijn B Katan, Frans J Kok and Petra Verhoef

1 From the Wageningen Centre for Food Sciences (AM-B, MBK, and PV) and the Division of Human Nutrition (AM-B, CEW, MBK, FJK, and PV), Wageningen University, Wageningen, Netherlands, and the Department of Gastroenterology and Hepatology, University Medical Centre, Nijmegen, Netherlands (CEW).

Background: The bioavailability of dietary folate has been estimated to be {approx}50% of that of synthetic folic acid. Folate in the diet is linked to a polyglutamate chain that may restrict folate absorption.

Objective: Our goal was to quantify the bioavailability and bioefficacy of low doses of polyglutamyl folic acid relative to that of monoglutamyl folic acid.

Design: In total, 180 men and women aged 50-75 y ingested capsules containing 323 nmol heptaglutamyl folic acid/d or 262 nmol monoglutamyl folic acid/d or placebo in a randomized parallel trial. Serum and erythrocyte folate and plasma homocysteine concentrations were measured after an overnight fast at baseline and after 12 wk of intervention.

Results: Mean serum and erythrocyte folate concentrations increased less in the polyglutamyl folic acid group [6.1 (95% CI: 5.3, 7.0) and 155 (122, 188) nmol/L, respectively] than in the monoglutamyl folic acid group [11.8 (10.3, 13.3) and 282 (246, 318) nmol/L, respectively]. Differences remained statistically significant (P < 0.05) after correction for the difference in the amount of folic acid administered. The decrease in plasma homocysteine concentrations did not differ significantly between treatment groups [polyglutamyl: -12.1% (-14.8%, -9.3%); monoglutamyl: -14.1% (-16.3%, -11.9%)]. The relative bioavailability of polyglutamyl folic acid was 64% (52%, 75%) on the basis of serum folate and was 68% (51%, 84%) on the basis of erythrocyte folate concentrations. Bioefficacy, determined by changes in plasma homocysteine concentrations, was 106% (77%, 134%).

Conclusion: The polyglutamate chain of folates in the diet reduces their bioavailability.

Key Words: Polyglutamyl folic acid • monoglutamyl folic acid • folic acid • bioavailability • bioefficacy • serum folate • erythrocyte folate • plasma homocysteine




This article has been cited by other articles:


Home page
J. Nutr.Home page
M. Verwei, A. P. Freidig, R. Havenaar, and J. P. Groten
Predicted Serum Folate Concentrations Based on In Vitro Studies and Kinetic Modeling are Consistent with Measured Folate Concentrations in Humans
J. Nutr., December 1, 2006; 136(12): 3074 - 3078.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Melse-Boonstra, P. Verhoef, C. E West, J. A van Rhijn, R. B van Breemen, J. J. Lasaroms, S. D Garbis, M. B Katan, and F. J Kok
A dual-isotope-labeling method of studying the bioavailability of hexaglutamyl folic acid relative to that of monoglutamyl folic acid in humans by using multiple orally administered low doses.
Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1128 - 1133.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. J McKillop, H. McNulty, J. M Scott, J. M McPartlin, J. Strain, I. Bradbury, J. Girvan, L. Hoey, R. McCreedy, J. Alexander, et al.
The rate of intestinal absorption of natural food folates is not related to the extent of folate conjugation
Am. J. Clinical Nutrition, July 1, 2006; 84(1): 167 - 173.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. L. Yang, J. Hung, M. A. Caudill, T. F. Urrutia, A. Alamilla, C. A. Perry, R. Li, H. Hata, and E. A. Cogger
A Long-Term Controlled Folate Feeding Study in Young Women Supports the Validity of the 1.7 Multiplier in the Dietary Folate Equivalency Equation
J. Nutr., May 1, 2005; 135(5): 1139 - 1145.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Brevik, S. E. Vollset, G. S Tell, H. Refsum, P. M. Ueland, E. B. Loeken, C. A Drevon, and L. F. Andersen
Plasma concentration of folate as a biomarker for the intake of fruit and vegetables: the Hordaland Homocysteine Study
Am. J. Clinical Nutrition, February 1, 2005; 81(2): 434 - 439.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The American Society for Nutrition